Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascale Tomasini

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Journal of Psychosocial Oncology|December 27, 2018
"I think it's a bit early for now": impact of psychological factors on drafting advance directives among cancer patientsPatrice Cannone, Pascale Tomasini, Merlin Paul, et al.
Expert Review of Anticancer Therapy|December 5, 2018
Therapeutic potential of trametinib to inhibit the mutagenesis by inactivating the protein kinase pathway in non-small cell lung cancerArnaud Jeanson, Arnaud Boyer, Laurent Greillier, et al.
American Journal of Clinical Oncology|August 31, 2022
Severe Immune Checkpoint Inhibitor Toxicity Leading to ICU Admission in Patients With Solid TumorsMarine Leprince, Bertrand Pourroy, Mohamed Boucekine, et al.
Translational Cancer Research|February 4, 2022
First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancerCamille Travert, Pascale Tomasini, Arnaud Jeanson, et al.
Bulletin Du Cancer|March 20, 2026
[Summary of second-line treatment of stage IV NSCLC without oncogenic addiction]Thomas Pierret, Renaud Descourt, Romain Corre, et al.
The Oncologist|November 4, 2016
Targeting the KRAS Pathway in Non-Small Cell Lung CancerPascale Tomasini, Preet Walia, Catherine Labbe, et al.
Therapeutic Advances in Respiratory Disease|February 22, 2019
Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastasesPascale Tomasini, Julie Egea, Maxime Souquet-Bressand, et al.
Bulletin Du Cancer|September 29, 2012
[β-Human chorionic gonadotropin (HCG) dosage and lung cancer: a pitfall when screening patients for clinical trials]Nataliya Khobta, Pascale Tomasini, Marie-Eve Garcia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 23, 2015
Diffuse Hemorrhagic Brain Metastases in an ALK Fusion Positive Patient on CrizotinibKevin Jao, Pascale Tomasini, Catherine Labbe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2015
Tumor relapse after thoracic surgery?Marie-Eve Garcia, Pascale Tomasini, Pascal Thomas, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Journal of Psychosocial Oncology|December 27, 2018
"I think it's a bit early for now": impact of psychological factors on drafting advance directives among cancer patientsPatrice Cannone, Pascale Tomasini, Merlin Paul, et al.
Expert Review of Anticancer Therapy|December 5, 2018
Therapeutic potential of trametinib to inhibit the mutagenesis by inactivating the protein kinase pathway in non-small cell lung cancerArnaud Jeanson, Arnaud Boyer, Laurent Greillier, et al.
American Journal of Clinical Oncology|August 31, 2022
Severe Immune Checkpoint Inhibitor Toxicity Leading to ICU Admission in Patients With Solid TumorsMarine Leprince, Bertrand Pourroy, Mohamed Boucekine, et al.
Translational Cancer Research|February 4, 2022
First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancerCamille Travert, Pascale Tomasini, Arnaud Jeanson, et al.
Bulletin Du Cancer|March 20, 2026
[Summary of second-line treatment of stage IV NSCLC without oncogenic addiction]Thomas Pierret, Renaud Descourt, Romain Corre, et al.
The Oncologist|November 4, 2016
Targeting the KRAS Pathway in Non-Small Cell Lung CancerPascale Tomasini, Preet Walia, Catherine Labbe, et al.
Therapeutic Advances in Respiratory Disease|February 22, 2019
Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastasesPascale Tomasini, Julie Egea, Maxime Souquet-Bressand, et al.
Bulletin Du Cancer|September 29, 2012
[β-Human chorionic gonadotropin (HCG) dosage and lung cancer: a pitfall when screening patients for clinical trials]Nataliya Khobta, Pascale Tomasini, Marie-Eve Garcia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 23, 2015
Diffuse Hemorrhagic Brain Metastases in an ALK Fusion Positive Patient on CrizotinibKevin Jao, Pascale Tomasini, Catherine Labbe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2015
Tumor relapse after thoracic surgery?Marie-Eve Garcia, Pascale Tomasini, Pascal Thomas, et al.
Pageof 10